Nomic Bio

Work at Nomic Bio?

Total raised$42.0M
StageSeries B
Hiring pace3 roles / 90d
Founded2017
Team size51-200 employees
HQMontreal, QC
Industries
BiotechnologyProteomicsLife SciencesDiagnostics

About Nomic Bio

Nomic develops a high-throughput proteomics platform to profile proteins at large scale. Its mission is to make biology easier to measure. Spun out of McGill University, Nomic is headquartered in Montreal, Canada, with a satellite research lab in Boston, Massachusetts, and the majority of its team based in Montreal. The company has partnered with dozens of drug discovery groups, including GSK and four of the top 10 pharmaceutical companies. It recently launched a manufacturing and protein profiling facility capable of multiplexed measurement of more than 2.5 million samples per year, generating the equivalent of 500 million protein assays.

Open positions · 4

Location

Culture & values

The majority of Nomic's team is based in Montreal and works in a new shared office/laboratory space with an in-person, but flexible work-from-home policy.

Nomic describes itself as building a diverse team of engineers, scientists, and world-changers.

The company values cross-disciplinary collaboration among engineers, scientists, and highly-skilled lab operators.

Nomic embraces a first principles approach to solving difficult problems.

The organization aims to grow quickly to meet customer demand while continuing to develop its core technology.

Life at Nomic Bio

Frequently asked questions

Companies similar to Nomic Bio

EVANIUM

EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.

Biotechnology1-10
Aira

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

HealthTech1-10
Aleph

Aleph is AI-native and designed to be the always-on decision layer for modern businesses, offering real-time data collaboration for finance teams and automating reporting, variance analysis, and forecasting. It operates as a global digital advertising powerhouse serving 150+ countries, connecting over 26,000 advertisers to a 3 billion consumer audience and partnering with major platforms such as TikTok, X, Microsoft, Amazon, Pinterest, Reddit, Spotify and Google. Its mission is to make the digital world accessible to all, while connecting global brands with local audiences in emerging markets and empowering businesses and individuals through its Digital Ad Expert education platform. The company also facilitates cross-border payments and credit underwriting through Local Payments by Aleph, supported by a team of over 1,500 digital experts in 75+ offices and backing from investors including CVC Partners, Mercado Libre, Sony, X (formerly Twitter), and Snap. Aleph serves a spectrum of clients from small startups to multinational corporations, boasting a trial-to-customer conversion rate exceeding 90%.

FinTech11-50